Controlled substance prescriptions for the PTCE

What a controlled prescription must contain to be valid, how each schedule may originate, the federal transfer warning verbatim, separate CII recordkeeping, and exempt narcotics.

The Controlled Substances Act (CSA)

The Controlled Substances Act is the federal statute that regulates scheduled drugs. The CSA reaches the entire supply-and-use chain — manufacturing, wholesaling, prescribing, dispensing, storage, records, and diversion safeguards. These medications get extra oversight because of abuse, diversion, dependence, and misuse concerns.

Certain precursor chemicals are also covered when they can be used to produce a controlled substance. A precursor is a chemical input that can be further processed into a controlled drug.

• Pseudoephedrine is the classic example — it can be diverted into illicit methamphetamine production.
• The Combat Methamphetamine Epidemic Act (CMEA) of 2005 regulates retail OTC sales of ephedrine and pseudoephedrine, limiting purchases to 3.6 grams per day and no more than 9 grams in a 30-day window (retail). Mail-order sales carry a lower 30-day cap of 7.5 grams. Phenylpropanolamine was historically a CMEA precursor but is no longer marketed in the US.

Every link in the controlled-substance chain — from manufacturers and distributors to pharmacies and prescribers — follows CSA rules. The goal is to prevent abuse, misuse, and diversion through the entire distribution network.

Exam Tip: When state and federal controlled-substance rules differ, the stricter rule governs. This is the single most-tested meta-rule on the PTCE for Section 2.2.

Controlled Substance Prescription Requirements

Federal controlled-substance prescriptions must contain these seven core elements:

1. Issue date
2. Patient identifying information — full name and address
3. Prescriber identifying information — address and DEA registration number
4. Medication details — drug name, strength, dosage form, quantity
5. Directions for use (sig)
6. Refill authorization — when refills are legally allowed for that schedule
7. Prescriber signature — unless a verbal emergency order is permitted

Exam Tip: The DEA number is the element most often missing on a problem prescription and the most common first test trap. The patient's Social Security number is never required. Know both.

New-Prescription Origination Rules by Schedule

PTCE Content Outline §2.2 explicitly tests three controlled-substance workflows as separate categories: NEW prescription, REFILL, and TRANSFER. The three are related but have different rules.

Validity Requirements

• A controlled-substance prescription must come from an authorized practitioner acting for a legitimate medical purpose in the usual course of the prescriber's professional practice.
• The prescriber needs proper state authority and, when applicable, active DEA registration (unless exempt, such as Public Health Service physicians).
• Corresponding responsibility doctrine: the pharmacist who fills a controlled-substance prescription is not a passive conduit. DEA regulation places a shared duty on that pharmacist to be satisfied the prescription is genuine — a real medical need, a properly authorized prescriber, ordinary clinical practice. A pharmacist who knowingly fills one that fails those tests can face criminal or civil penalties of their own, independent of whatever the prescriber did.

Pharmacist Call Required: When a red flag (early refill, pattern change, suspicious script) appears on a controlled-substance prescription, the technician's job is to hand off to the pharmacist. The "corresponding responsibility" decision is the pharmacist's. Do not resolve it at the counter.

Federal Transfer Warning (Verbatim)

Every dispensed container of a Schedule II, III, or IV controlled substance must bear the federal transfer warning label under 21 CFR 290.5. (Schedule V is not included in the federal mandate, though state law may add it.) The exact required statement is:

"Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed."

This warning must appear on the patient's prescription container. The PTCE tests the exact wording. Memorize it verbatim.

Manufacturer packaging also requires the "C" symbol with the Roman numeral indicating the schedule (CII, CIII, CIV, CV).

Separate CII Recordkeeping

• Schedule II records must be kept separately from Schedule III, IV, and V records (federal requirement).
• Records must be maintained for a minimum of 2 years and be readily retrievable for DEA inspection (21 CFR).

Schedule II Dispensing Rules

General Rule

For routine outpatient dispensing, a Schedule II medication is filled only from a properly signed written prescription or from a compliant DEA-valid electronic prescription.

Emergency Exception

During a qualifying emergency, the prescriber may give oral (telephoned) authorization to the pharmacist — the federal emergency exception is oral only, not fax (21 CFR 1306.11(d)). Then:

• The pharmacist must receive the original signed written prescription or compliant electronic prescription within 7 days.
• The prescription should note that it was issued for emergency dispensing.

Faxed CII Prescriptions

DEA rules accept a faxed Schedule II prescription only in a few narrowly defined situations:

• Patient residing in a long-term care (LTC) facility
• Hospice patient
• Patient receiving compounded home infusion/IV pain therapy

Tamper-Resistant Forms

• Some jurisdictions require state-approved tamper-resistant or multipart paper forms for Schedule II prescriptions.
• Tamper-resistant forms must prevent copying, erasure or modification, and use of counterfeit prescriptions.

CII Refill and Transfer Restrictions

• Schedule II prescriptions carry no refills.
• A one-time transfer of an electronic CII prescription for initial filling may be allowed at patient request when state law permits; otherwise CII transfers are generally prohibited.
• Every additional fill requires a separate new prescription.

Exempt Narcotics

Under limited federal circumstances, a pharmacist may dispense certain low-level controlled products without a standard prescription. These are sometimes called exempt narcotic products.

Federal criteria for dispensing exempt narcotics:

1. Dispensing authority rests with the pharmacist, even if another employee assists with the sale steps.
2. The buyer must meet the minimum age and present acceptable identification.
3. Federal law limits how much of the product may be sold within the permitted period.
4. The pharmacy records the transaction — purchaser, product, quantity, date, and pharmacist.

Example: A Schedule V cough syrup with a limited amount of codeine where both federal and state law permit dispensing. Some states require all controlled substances to be dispensed by prescription only. State law controls when it is stricter.

E-Prescribing for Controlled Medications (EPCS)

• Controlled prescriptions may be sent electronically when the prescriber and pharmacy systems meet DEA standards.
• The computer software used to transmit and receive electronic controlled-substance prescriptions must meet DEA's requirements. This is the EPCS (Electronic Prescriptions for Controlled Substances) standard. A certified EPCS application enforces two-factor prescriber authentication, audit trails, and tamper-evident storage.
• Some states now require electronic transmission for many controlled-substance prescriptions.
• The electronic version must contain the same core data elements required on a paper prescription.
• Electronic controlled-substance prescriptions must be stored electronically — not printed and filed as paper. Retain them in original electronic form with audit trail.

Common Traps

Here's where people miss it on Section 2.2:

• Reading "M" as the physician prefix. A DEA number that starts with M is a mid-level practitioner — NP, PA, optometrist, pharmacist with prescriptive authority. Physicians and other individual practitioners start with A, B, F, or G. "M for MD" feels intuitive and is wrong. The first letter is registrant type, not the prescriber's initial.
• Filling a CII written for "5 refills." Zero refills are permitted on Schedule II. Federal law overrides any prescriber marking. A "x 5" notation on a CII script is invalid; each subsequent fill needs a brand-new prescription. Do not extend the CIII/CIV refill rule across the schedule line.
• Transferring a paper CII because the patient asked. CII is generally non-transferable. The narrow exception is an electronic CII prescription, transferred one time, for initial filling, at patient request, when state law permits. Paper CII does not qualify, and the exception ends after the first fill — every subsequent fill requires a new prescription.
• Treating the 72-hour CII verbal emergency as a stand-alone permission. During a qualifying emergency the prescriber may phone in a CII — but only up to the supply needed for the emergency period (about 72 hours), and the pharmacist must receive the original signed written prescription (or compliant electronic) within 7 days. No 7-day paper, no completed transaction.
• Asking for a triplicate DEA Form 222. The legacy triplicate pads were retired in October 2021. The current paper form is the single-sheet DEA Form 222, or the electronic equivalent through CSOS. The exam still tests the form name and current format.
• Paraphrasing the federal transfer warning. The exact label text is: "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed." It must appear on every dispensed Schedule II, III, or IV container (21 CFR 290.5 — Schedule V is outside the federal mandate). The PTCE tests the wording verbatim.
• Placing testosterone or buprenorphine/naloxone at CII. Testosterone is CIII. Buprenorphine/naloxone (Suboxone®) is CIII. Students reach for CII because both are tightly controlled in practice, but the federal schedule does not change to match clinical sensitivity.
• Calling pregabalin CIV or tramadol CV. Pregabalin (Lyrica®) is CV. Tramadol (Ultram®) is CIV. Two of the most-tested misplacements on the section. Anchor each by drug, not by class feel.
• Confusing biennial with biannual on the inventory rule. Federal controlled-substance inventory is biennial — every 2 years. Biannual means twice per year. The two words sound identical, and the exam writes the swap as a classic distractor.
• Letting state law slide when it is stricter than federal. When federal and state controlled-substance rules conflict, the stricter rule governs. A federal "permitted" line does not override a state prohibition. Read both before answering.

Quick Review Checklist

A fast scan of the highest-yield Section 2.2 facts. If any line does not land, go back to the matching body section before moving on.

• Governing law — Controlled Substances Act (CSA), enacted 1970; enforced by the DEA (Department of Justice); rules live in 21 CFR.
• Five schedules — CI (no accepted medical use, not dispensed) through CV (lowest abuse potential).
• Schedule anchors — morphine/oxycodone/hydrocodone/fentanyl/methadone and stimulants like methylphenidate and amphetamine salts = CII; testosterone and buprenorphine/naloxone (Suboxone®) = CIII; alprazolam/lorazepam/diazepam, tramadol (Ultram®), zolpidem, phenobarbital = CIV; pregabalin (Lyrica®) and diphenoxylate/atropine (Lomotil®) = CV.
• DEA number format — 2 letters + 7 digits. First letter = registrant type (A/B/F/G physician, M mid-level, P/R manufacturer/distributor, X legacy DATA-waived). Second letter = first letter of the prescriber's last name.
• Check-digit math — add digits 1+3+5; add digits 2+4+6 and multiply by 2; sum the two; the last digit of that sum equals the 7th digit.
• Refill rules — CII: zero refills; CIII/CIV: up to 5 refills within 6 months; CV: no federal refill limit.
• Emergency verbal CII — up to the supply needed for the emergency period (about 72 hours); the prescriber must provide the written/electronic follow-up within 7 days.
• Faxed CII — permitted for LTC, hospice, and home-infusion/IV pain therapy patients.
• CII transfer — generally not transferable; narrow exception is an electronic CII, one time, for initial filling, at patient request, when state law permits.
• Seven required Rx elements — issue date; patient name and address; prescriber name, address, and DEA number; drug name, strength, dosage form, quantity; directions; refill authorization (if any); prescriber signature. Patient SSN is not required.
• Federal transfer warning (verbatim) — "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed." Required on every dispensed Schedule II, III, or IV container (21 CFR 290.5; not Schedule V).
• DEA Form 222 — legacy triplicate retired October 2021; the current single-sheet Form 222 allows up to 20 line items (legacy triplicate allowed 10). CSOS is the electronic equivalent and has no line-item limit. (Form 222 ordering workflow is covered in SG 2.3.)
• CMEA — Combat Methamphetamine Epidemic Act, 2005; pseudoephedrine limits 3.6 g/day and 9 g/30 days.
• Records — federal minimum retention 2 years, readily retrievable; CII records filed separately from CIII/IV/V; biennial (every 2 years) inventory.
• Corresponding responsibility — the pharmacist must dispense only for a legitimate medical purpose; filling a suspect CS prescription carries penalties even when the prescriber is the one misprescribing.
• State vs. federal — when the two conflict, the stricter rule governs.

Related

DEA schedules, refills and transfers · What is on the PTCE and how it is weighted · All Federal Requirements guides